Case fatality rates for patients with COVID-19 requiring invasive mechanical ventilation. A meta-analysis

ZJ Lim, A Subramaniam, M Ponnapa Reddy… - American journal of …, 2021 - atsjournals.org
Rationale: Initial reports of case fatality rates (CFRs) among adults with coronavirus disease
(COVID-19) receiving invasive mechanical ventilation (IMV) are highly variable. Objectives …

Ivermectin for preventing and treating COVID‐19

M Popp, M Stegemann, MI Metzendorf… - Cochrane Database …, 2021 - cochranelibrary.com
Background Ivermectin, an antiparasitic agent used to treat parasitic infestations, inhibits the
replication of viruses in vitro. The molecular hypothesis of ivermectin's antiviral mode of …

Resistance of Omicron subvariants BA. 2.75. 2, BA. 4.6, and BQ. 1.1 to neutralizing antibodies

D Planas, T Bruel, I Staropoli… - Nature …, 2023 - nature.com
Convergent evolution of SARS-CoV-2 Omicron BA. 2, BA. 4, and BA. 5 lineages has led to
the emergence of several new subvariants, including BA. 2.75. 2, BA. 4.6. and BQ. 1.1. The …

Complement and tissue factor–enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis

P Skendros, A Mitsios… - The Journal of …, 2020 - Am Soc Clin Investig
Emerging data indicate that complement and neutrophils contribute to the maladaptive
immune response that fuels hyperinflammation and thrombotic microangiopathy, thereby …

COVID-19 and orbital mucormycosis

S Sarkar, T Gokhale, SS Choudhury… - Indian Journal of …, 2021 - journals.lww.com
Dear Editor, The 2019 novel coronavirus (2019-nCoV) or severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) first reported in Wuhan, Hubei province in China, quickly …

COVID-19: unmasking emerging SARS-CoV-2 variants, vaccines and therapeutic strategies

R Raman, KJ Patel, K Ranjan - Biomolecules, 2021 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of
the coronavirus disease 2019 (COVID-19) pandemic, which has been a topic of major …

Azithromycin in the treatment of COVID-19: a review

D Echeverría-Esnal, C Martin-Ontiyuelo… - Expert review of anti …, 2021 - Taylor & Francis
Introduction SARS-CoV-2 is a novel virus that causes coronavirus disease-19 (COVID-19).
Antiviral and immunomodulatory agents have been proposed as potential treatments …

Coronavirus and Cardiovascular Disease, Myocardial Injury, and Arrhythmia: JACC Focus Seminar

G Giustino, SP Pinney, A Lala, VY Reddy… - Journal of the American …, 2020 - jacc.org
The cardiovascular system is affected broadly by severe acute respiratory syndrome
coronavirus 2 infection. Both direct viral infection and indirect injury resulting from …

Review of current COVID-19 diagnostics and opportunities for further development

Y Mardian, H Kosasih, M Karyana, A Neal… - Frontiers in …, 2021 - frontiersin.org
Diagnostic testing plays a critical role in addressing the coronavirus disease 2019 (COVID-
19) pandemic, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV …

Chloroquine or hydroxychloroquine for prevention and treatment of COVID‐19

B Singh, H Ryan, T Kredo, M Chaplin… - Cochrane Database …, 2021 - cochranelibrary.com
Background The coronavirus disease 2019 (COVID‐19) pandemic has resulted in
substantial mortality. Some specialists proposed chloroquine (CQ) and hydroxychloroquine …